Catalyst Crew Technologies Seeks FINRA Approval for Name and Symbol Change to LataMed AI Corp.

Catalyst Crew Technologies Corp. has submitted a corporate action request to FINRA to change its name to LataMed AI Corp. and its trading symbol, reflecting its strategic shift toward AI-enabled healthcare technology focused on Latin America.

Miami Metrowire Staff
Healthcare
Catalyst Crew Technologies Seeks FINRA Approval for Name and Symbol Change to LataMed AI Corp.

Catalyst Crew Technologies Corp. (OTC: CCTC) announced today that it has submitted a corporate action request to the Financial Industry Regulatory Authority (FINRA) seeking approval to change its corporate name to LataMed AI Corp. and to adopt a corresponding new trading symbol. The proposed changes are designed to align the Company's public identity with its strategic transition into artificial intelligence-enabled healthcare technology, with an initial focus on Latin America.

The Company's Board of Directors and majority shareholder have approved the corporate action, which does not involve any reverse stock split, forward stock split, recapitalization, change to authorized capital, or other modification to the capital structure. The issued and outstanding share count will remain unchanged, and shareholders will not need to take any action.

Dr. Kevin Rodan Levy, Chief Executive Officer, stated, "There is no change to the Company's capital structure as part of this process. This proposed name change is intended to better align the Company's public identity with its healthcare technology strategy and long-term market focus."

Upon FINRA approval, the Company intends to file a Certificate of Amendment with the Nevada Secretary of State to effect the name change. The changes would become effective after the required filings and publication by FINRA on the Daily List. There is no guarantee that FINRA will approve the name change, the requested new trading symbol, or the timing of any such approval.

Catalyst Crew Technologies Corp. is an artificial intelligence-driven healthcare technology company focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America. The Company is actively executing its strategic transition into AI-enabled healthcare and pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.

For more information, visit the Company's website at https://catalystcrewai.com or review its filings with the U.S. Securities and Exchange Commission at www.sec.gov.

Blockchain Registration

QR Code for Blockchain Registration